Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNP | P00491 | 10/20 | 1.00 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.58 |
| ▸ | FGFR2 | P21802 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5677631 | 0.89 | PNP (0.80) | PNPKMT2A | |
| SCHEMBL985175 | 0.87 | PNP (0.77) | PNPFGFR1FGFR2 | |
| SCHEMBL3303807 | 0.87 | PNP (0.77) | PNPFGFR1FGFR2 | |
| SCHEMBL6268526 | 0.87 | PNP (0.77) | PNPFGFR1FGFR2 | |
| SCHEMBL4966457 | 0.87 | PNP (0.77) | PNPFGFR1FGFR2 | |
| SCHEMBL17186254 | 0.86 | PNP (0.75) | PNPFGFR1FGFR2 | |
| SCHEMBL3021038 | 0.86 | PNP (0.75) | PNPFGFR1FGFR2 | |
| SCHEMBL3310268 | 0.86 | PNP (0.75) | PNPFGFR1FGFR2 | |
| SCHEMBL3308558 | 0.86 | PNP (0.75) | PNPFGFR1FGFR2 | |
| Hydrochloric Acid SCHEMBL2777605 | 0.86 | PNP (0.75) | PNPFGFR1FGFR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6614 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4746918-A1 | METHODS OF PREPARING SURFACE MODIFIED VIRAL CAPSIDS | Borea Therapeutics S.r.l. (IT) | 2026-05-27 | — | — | EP | claimed |
| WO-2026101423-A1 | PHOTOSWITCHABLE CHEMICAL INDUCED DIMERIZATION SYSTEMS FOR CONTROL OF CELLULAR ACTIVITIES WITH LIGHT | WU YAOWEN (SE) | 2026-05-15 | — | — | WO | claimed |
| US-20260130982-A1 | METHODS FOR ASSEMBLING PROTEIN-CONJUGATED NANOCARRIER VACCINES | UNIV NORTHWESTERN (US) | 2026-05-14 | — | — | US | claimed |
| US-20260116861-A1 | ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-04-30 | — | — | US | claimed |
| WO-2026085618-A1 | METHOD OF IMMOBILIZING CAPTURE PROBES TO SOLID PHASES FOR TARGET SUBSTANCE DETECTION | YYZ PHARMATECH INC. (CA) | 2026-04-30 | — | — | WO | claimed |
| US-20260103737-A1 | ENZYMATIC METHODS TO GENERATE HIGH YIELDS OF SEQUENCE SPECIFIC RNA OLIGONUCLEOTIDES WITH EXTREME PRECISION | UNIV MASSACHUSETTS (US) | 2026-04-16 | — | — | US | claimed |
| EP-4716533-A2 | FLUORESCENT INDICATORS FOR METAL ION DETECTION AS SUBSTRATES FOR A SELF-LABELING ENZYME | Ion Biosciences (US) | 2026-04-01 | — | — | EP | claimed |
| EP-3336099-B1 | METHOD FOR SELECTIVELY BINDING CELLS TO A BINDING PARTNER AND DEVICE COMPRISING CELLS | KARLSRUHER INST TECHNOLOGIE (DE) | 2026-03-04 | — | — | EP | claimed |
| US-12560608-B2 | Detection of molecular associations | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2026-02-24 | — | — | US | claimed |
| EP-4688872-A1 | CLICK-TO-INSTALL GENOME EDITING | The General Hospital Corporation (US) | 2026-02-11 | — | — | EP | claimed |
| EP-1054890-A1 | OLIGODEOXYRIBONUCLEOTIDES COMPRISING O6-BENZYLGUANINE AND THEIR USE | THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, Department of Health and Human Services (US) | 2000-11-29 | — | — | EP | claimed |
| WO-1999041269-A1 | OLIGODEOXYRIBONUCLEOTIDES COMPRISING O6-BENZYLGUANINE AND THEIR USE | THE UNITED STATES OF AMERICA, REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1999-08-19 | — | — | WO | claimed |
| EP-0922458-A1 | Potentiation of temozolomide by an ATase inhibitor | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1999-06-16 | — | — | EP | claimed |
| WO-1999025386-A1 | delta-O6-METHYLGUANINE-DNA METHYLTRANSFERASE GENE TRANSFER FOR O6-BENZYLGUANINE AND (N,N'-BIS(2-CHLOROETHYL)-N-NITROSOUREA) RESISTANCE | CASE WESTERN RESERVE UNIVERSITY (US) | 1999-05-27 | — | — | WO | claimed |
| EP-0910246-A1 | USE OF MUTANT ALKYLTRANSFERASES FOR GENE THERAPY TO PROTECT FROM TOXICITY OF THERAPEUTIC ALKYLATING AGENTS | THE PENN STATE RESEARCH FOUNDATION (US) | 1999-04-28 | — | — | EP | claimed |
| WO-1997035477-A1 | USE OF MUTANT ALKYLTRANSFERASES FOR GENE THERAPY TO PROTECT FROM TOXICITY OF THERAPEUTIC ALKYLATING AGENTS | THE PENN STATE RESEARCH FOUNDATION (US) | 1997-10-02 | — | — | WO | claimed |
| EP-0775142-A1 | SUBSTITUTED O6 -BENZYLGUANINES AND 6(4)-BENZYLOXYPYRIMIDINES | THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, Department of Health and Human Services (US) | 1997-05-28 | — | — | EP | claimed |
| WO-1996004281-A1 | SUBSTITUTED O6-BENZYLGUANINES AND 6(4)-BENZYLOXYPYRIMIDINES | THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1996-02-15 | — | — | WO | claimed |
| EP-0679086-A1 | POTENTIATION OF TEMOZOLOMIDE IN HUMAN TUMOUR CELLS | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1995-11-02 | — | — | EP | claimed |
| WO-1994015615-A1 | POTENTIATION OF TEMOZOLOMIDE IN HUMAN TUMOUR CELLS | CANCER RESEARCH CAMPAIGN TECHNOLOGY, LTD. (GB) | 1994-07-21 | — | — | WO | claimed |